| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Dairy Science, The Ohio State University, Ohio Agricultural Research and Development Center, Wooster 44691
Efficacy of an Escherichia coli (O111:B4) J5 bacterin for preventing naturally occurring IMI and clinical mastitis was tested in a 2.5-yr field trial in a 225-cow commercial herd. Cows with odd-numbed identification were vaccinated, and cows with even-numbered identification served as unvaccinated controls for each lactation during the study. Immunizations were subcutaneuus on the upper part of the rib cage just posterior to the scapula at drying off, 30 d after drying off, and at calving. Percentage of quarters infected at calving with Gram-negative bacteria did not differ between treatment groups. A total of 67% of Gram-negative bacterial IMI present at calving in control cows became clinical during the first 90 d of lactation compared with 20% in vaccinated cows. Rate of Gram-negative bacterial clinical mastitis was higher in control cows than in vaccinated cows during the first 90 d of lactation. Immunization with the E. coli J5 bacterin did not reduce level of Gram-negative bacterial IMI at calving but did reduce incidence of clinical mastitis.
Key Words: Escherichia coli • vaccine • mastitis
Submitted on June 12, 1991
Accepted on September 6, 1991
This article has been cited by other articles:
|
|
 |
|
  D. D. Bannerman, A. C. W. Kauf, M. J. Paape, H. R. Springer, and J. P. Goff Comparison of Holstein and Jersey Innate Immune Responses to Escherichia coli Intramammary Infection J Dairy Sci, June 1, 2008; 91(6): 2225 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Wilson, Y. T. Grohn, G. J. Bennett, R. N. Gonzalez, Y. H. Schukken, and J. Spatz Comparison of J5 Vaccinates and Controls for Incidence, Etiologic Agent, Clinical Severity, and Survival in the Herd Following Naturally Occurring Cases of Clinical Mastitis J Dairy Sci, September 1, 2007; 90(9): 4282 - 4288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Wilson, B. A. Mallard, J. L. Burton, Y. H. Schukken, and Y. T. Grohn Milk and Serum J5-Specific Antibody Responses, Milk Production Change, and Clinical Effects following Intramammary Escherichia coli Challenge for J5 Vaccinate and Control Cows Clin. Vaccine Immunol., June 1, 2007; 14(6): 693 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Detilleux, F. Vangroenweghe, and C. Burvenich Mathematical Model of the Acute Inflammatory Response to Escherichia coli in Intramammary Challenge. J Dairy Sci, September 1, 2006; 89(9): 3455 - 3465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Hogan, V. B. Cannon, K. L. Smith, C. Rinehart, and S. Miller Effects of Adjuvants on Safety and Efficacy of an Escherichia coli J5 Bacterin J Dairy Sci, February 1, 2005; 88(2): 534 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, J. S. Hogan, and K. L. Smith Antigenic Homology of the Inducible Ferric Citrate Receptor (FecA) of Coliform Bacteria Isolated from Herds with Naturally Occurring Bovine Intramammary Infections Clin. Vaccine Immunol., November 1, 1999; 6(6): 966 - 969. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
